3. DENTOXOL® ENTERS GES PROGRAMME
Ingalfarma announces that its product Dentoxol® has been incorporated into the GES programme of one of the most important health insurance companies in the country, in prophylaxis of oral mucositis in lung cancer.
Ingalfarma announces that its product Dentoxol® has been incorporated into the GES programme of one of the most important health insurance companies in the country, in prophylaxis of oral mucositis in lung cancer.
Ingalfarma anuncia que su producto Dentoxol® ha sido incorporado en la canasta GES, de una de las isapres más importantes del país, en profilaxis de mucositis oral en cáncer de pulmón.